--- title: "Apogee Enterprises Posts Strong Q1 Earnings, Joins ACADIA Pharmaceuticals, Crocs And Other Big Stocks Moving Higher On Friday" type: "News" locale: "en" url: "https://longbridge.com/en/news/290981338.md" description: "Apogee Enterprises shares surged 13.2% after reporting Q1 earnings of $0.57 per share and net sales of $342.7 million, beating estimates. Other notable gainers included FuelCell Energy (+17.6%) following a Jefferies upgrade, ACADIA Pharmaceuticals (+10.3%) on positive EMA authorization recommendation for DAYBU, and Crocs (+5.8%) after a Piper Sandler upgrade. The broader U.S. market saw slight declines, with the Dow Jones falling 0.1%." datetime: "2026-06-26T14:18:56.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/290981338.md) - [en](https://longbridge.com/en/news/290981338.md) - [zh-HK](https://longbridge.com/zh-HK/news/290981338.md) --- # Apogee Enterprises Posts Strong Q1 Earnings, Joins ACADIA Pharmaceuticals, Crocs And Other Big Stocks Moving Higher On Friday U.S. stocks were slightly lower, with the Dow Jones index falling around 0.1% on Friday. Shares of **Apogee Enterprises In**c (NASDAQ:APOG) rose sharply after the company reported better-than-expected first-quarter financial results. Adjusted diluted earnings came in at 57 cents per share, topping the analyst consensus estimate of 45 cents. Net sales totaled $342.7 million, ahead of the $333.8 million estimate. Apogee Enterprises shares jumped 13.2% to $48.07 on Friday. Here are some other big stocks recording gins in today’s session. - **FuelCell Energy Inc** (NASDAQ:FCEL) shares jumped 17.6% to $23.11. Jefferies analyst Dushyant Ailani upgraded FuelCell Energy from Hold to Buy and raised the price target from $16 to $24. - **BitVentures Limited** (NASDAQ:BVC) gained 14.1% to $10.09. - **ACADIA Pharmaceuticals Inc** (NASDAQ:ACAD) jumped 10.3% to $26.16 after the company announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency recommended the granting of a market authorization for DAYBU. - **Sellas Life Sciences Group Inc** (NASDAQ:SLS) gained 10.2% to $11.60. - Moderna Inc (NASDAQ:MRNA) gained 9.4% to $65.38. - **Xunlei Ltd** (NASDAQ:XNET) rose 9% to $5.48. Xunlei announced a $20 million share buyback program beginning July 1. - **Pulse Biosciences In**c (NASDAQ:PLSE) jumped 8.8% to $29.92. - **Century Therapeutics Inc** (NASDAQ:IPSC) gained 8.7% to $2.50. - **Cantor Equity Partners II In**c (NASDAQ:CEPT) jumped 8.3% to $10.99. Cantor Equity Partners II and Securitize expect to raise $400 million following business combination. - **ARS Pharmaceuticals Inc** (NASDAQ:SPRY) gained 8.2% to $8.68. ARS Pharmaceuticals on Wednesday reaffirmed its expectation to achieve cash-flow breakeven in 2027, even as no additional commercial formulary decisions for its epinephrine nasal spray Neffy were secured during the July 1, 2026 coverage cycle. - **ServiceNow Inc** (NYSE:NOW) rose 6.4% to $95.32. - BlackBerry Ltd (NYSE:BB) rose 6.4% to $11.00. BlackBerry recently reported fiscal first-quarter revenue of $152.9 million, up 26% from a year earlier and ahead of analyst estimates. - **Eli Lilly And C**o (NYSE:LLY) gained 6% to $1,195.89. Eli Lilly received EMA CHMP positive opinion for Jaypirca in chronic lymphocytic leukemia. - **Crocs Inc** (NASDAQ:CROX) jumped 5.8% to $125.77. Piper Sandler analyst Anna Andreeva upgraded Crocs from Neutral to Overweight and raised the price target from $95 to $150. - **Kodiak Sciences Inc** (NASDAQ:KOD) gained 5.3% to $35.88. _Photo via Shutterstock_ ### Related Stocks - [ACAD.US](https://longbridge.com/en/quote/ACAD.US.md) - [APOG.US](https://longbridge.com/en/quote/APOG.US.md) - [CROX.US](https://longbridge.com/en/quote/CROX.US.md) - [FCEL.US](https://longbridge.com/en/quote/FCEL.US.md) - [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md) - [BVC.US](https://longbridge.com/en/quote/BVC.US.md) - [SLS.US](https://longbridge.com/en/quote/SLS.US.md) - [MRNA.US](https://longbridge.com/en/quote/MRNA.US.md) - [XNET.US](https://longbridge.com/en/quote/XNET.US.md) - [PLSE.US](https://longbridge.com/en/quote/PLSE.US.md) - [IPSC.US](https://longbridge.com/en/quote/IPSC.US.md) - [CEPT.US](https://longbridge.com/en/quote/CEPT.US.md) - [SPRY.US](https://longbridge.com/en/quote/SPRY.US.md) - [NOW.US](https://longbridge.com/en/quote/NOW.US.md) - [BB.US](https://longbridge.com/en/quote/BB.US.md) - [LLY.US](https://longbridge.com/en/quote/LLY.US.md) - [KOD.US](https://longbridge.com/en/quote/KOD.US.md) ## Related News & Research - [ACADIA Pharmaceuticals Expands DAYBUE, NUPLAZID Reach Ahead of Key Alzheimer’s Data](https://longbridge.com/en/news/295699458.md) - [Mark Schneyer Sells 5,849 Shares of ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock](https://longbridge.com/en/news/295283718.md) - [Acadia Pharmaceuticals CFO Mark C. Schneyer disposes of 25,141 common shares worth $730,047.52](https://longbridge.com/en/news/295281807.md) - [Acadia Pharmaceuticals Q2 revenue rises on DAYBUE STIX demand, lifts 2026 outlook](https://longbridge.com/en/news/294866410.md) - [ACAD: DAYBUE STIX is quickly overtaking the original formulation as European launch preparations advance](https://longbridge.com/en/news/295698675.md)